Lyra Therapeutics Inc.

NASDAQ: LYRA · Real-Time Price · USD
7.06
-0.04 (-0.56%)
At close: Aug 15, 2025, 3:59 PM
6.87
-2.69%
After-hours: Aug 15, 2025, 06:51 PM EDT

Lyra Therapeutics Ratios and Metrics

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
PE Ratio
-7.19 -207.94 -85.88 -65.06
PEG Ratio
-0.53 6.68 1.89 -2.22
PS Ratio
438.05 8.37K 3.48K 9.93K
PB Ratio
57.96 145.76 58.78 82.50
P/FCF Ratio
-9.29 -202.54 -109 -96.93
P/OCF Ratio
-9.6 -205.89 -109.42 -109.64
OCF/S Ratio
-45.64 -40.63 -31.83 -90.6
Debt / Equity Ratio
2.97 0.30 0.05 0.04
Quick Ratio
3.41 5.35 6.97 2.63
Current Ratio
3.41 5.35 6.97 2.63
Asset Turnover
0.02 0.01 0.01 0.01
Interest Coverage
n/a n/a n/a n/a
Return on Equity
-8.06 -0.7 -0.68 -1.27
Return on Assets
-1.41 -0.44 -0.5 -0.79
Return on Invested Capital
-1.67 -0.52 -0.55 -1.12
Dividend Yield
n/a n/a n/a n/a
Payout Ratio
n/a n/a n/a n/a
Gross Profit Margin
1.00 1.00 0.22 -2.51
Net Profit Margin
-60.91 -40.23 -40.56 -152.68
Pretax Profit Margin
-60.88 -40.19 -40.55 -152.68
Operating Profit Margin
-62.81 -43.08 -41.31 -153.04
FCF Margin
n/a n/a n/a n/a
EBITDA Margin
-39.28 -41.88 -39.56 -149.52